MedTrace Logo

RIGHT: Rhythm ID Going Head-to-Head Trial

NCT00148954 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1962

Last updated 2012-01-12

Study results available
· View outcomes & findings →

Summary

RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.

Conditions

  • Tachycardia

Interventions

DEVICE

VITALITY 2 Implantable Cardioverter Defibrillator

VITALITY 2 ICD

DEVICE

Medtronic Implantable Cardioverter Defibrillator

Maximo, Marquis, Intrinsic, Virtuoso, or Entrust ICD

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Gold, MD, PhD · Medical University of South Carolina

  • Ron Berger, MD, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2009-03-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00148954 on ClinicalTrials.gov